Abstract
Antibody therapies have become an important component in the management of malignant disease. Antibodies can block tumour growth factors or their receptors, activate immunological attack on the tumour, and are used to deliver payloads such as radioisotopes, cytotoxic drugs or toxins. Immunotoxins are a new class of antitumour agents consisting of tumour- selective ligands (generally monoclonal antibodies [MoAbs]) linked to highly toxic protein molecules and take the advantage of the exquisite specificity of antibodies to selectively target drug delivery and the potency of toxins to kill the target cells. Toxins are modified to remove their normal tissue-binding domains by genetic engineering. Analysis of the aminoacid sequence of the region specific for immunogenecity and the signal transduction mechanisms involved in the interaction of immunotoxins with tumour cells will give the clue for the development of most efficient immunotoxins.
Highlights
M e payloads such as radioisotopes, cytotoxic drugs or toxins
Immunotoxins are a c new class of antitumour agents consisting of tumour- selective ligands linked to highly toxic protein molecules and JS te take the advantage of the exquisite specificity of antibodies to selectively target drug delivery and the potency of toxins to kill the target cells
Immunologic proteins that Clinical Application: are smaller than monoclonal antibodies (MoAbs), like growth factors and cytokines, Since antibodies have high molecular mass, have been chemically conjugated and they have a hard time penetrating solid cancer genetically fused to protein toxins
Summary
Immunotoxins are a c new class of antitumour agents consisting of tumour- selective ligands (generally R m monoclonal antibodies [MoAbs]) linked to highly toxic protein molecules and JS te take the advantage of the exquisite specificity of antibodies to selectively target drug delivery and the potency of toxins to kill the target cells. Definition of Immunotoxin: Immunotoxins are demonstrating the required specific binding proteins that contain a toxin along with an activity can be grown in large quantities, and antibody or growth factor that binds the monoclonal antibodies can be harvested to target cells.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
